恆隆地產(00101.HK)旗下商場8月推消費券及疫苗接種優惠
恆隆地產(00101.HK)公佈,爲支持港府消費券計劃,將於即發放第一期電子消費券當天(8月1日),推出跨商場推廣活動 消費券獎賞計劃。顧客於8月1日至10月31日推廣期內在恆隆旗下商場以電子消費每滿800元,即可獲200元之電子購物禮券。
另外,集團又公佈總值逾1,000萬元的「恆隆接種疫苗鼓勵計劃」供市民參與部分的詳情,於今年9月30日或之前完成接種兩劑2019冠狀病毒病疫苗的市民,只需登記成爲恆隆商場獎賞計劃會員,並於今年8月1日至10月31日期間於恆隆商場,以單一電子消費滿100元,即獲發總值200元的恆隆電子購物禮券。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.